The ALCOA+ requirements defined by the FDA establish, among others, the characteristics for correct identification of employees in regulated pharmaceutical processes. The use of biometrics solves the current difficulties in meeting them.

Current employee identification methods in pharmaceutical manufacturing processes cause data integrity breaches in GMP regulated environments, which can be solved with biometrics.